FADS2 and chronic kidney disease: The effects of supplementation with n-3 LCPUFA that were observed in the patients with chronic kidney disease were fairly well replicated in the cohort of healthy individuals in terms of the number and location of the CpGs that were changed in both FADS2 and ELOVL5, and the direction of the effect on these genes.